Piper Sandler Maintains Overweight on Teradyne, Lowers Price Target to $127
Piper Sandler analyst Weston Twigg maintains Teradyne (NASDAQ:TER) with a Overweight and lowers the price target from $163 to $127.
Teradyne: Dividend Insights
Monday marks the last chance for investors to receive the next dividend payout from Teradyne (NASDAQ:TER).
Teradyne Q1 Adj. EPS $0.98 Beats $0.88 Estimate, Sales $755.00M Beat $740.98M Estimate
Teradyne (NASDAQ:TER) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.88 by 11.36 percent. This is a 11.71 percent decrease over earnings of $1.11 per share from the same
Here’s How Much $100 Invested In Teradyne 5 Years Ago Would Be Worth Today
Teradyne (NASDAQ:TER) has outperformed the market over the past 5 years by 14.63% on an annualized basis producing an average annual return of 28.2%. Currently, Teradyne has a market capitalization of $17.79 billion.
Expert Ratings For Teradyne
Analysts have provided the following ratings for Teradyne (NASDAQ:TER) within the last quarter:
Goldman Sachs Downgrades Teradyne to Neutral, Announces $127 Price Target
Goldman Sachs analyst Toshiya Hari downgrades Teradyne (NASDAQ:TER) from Buy to Neutral and announces $127 price target.
Benzinga’s Daily Brief On Trending Tickers For March 9, 2022: Barclays Bank iPath Pure Beta Crude Oil ETN, ZIM Integrated Shipping Services, GameStop And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.
The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.
Cannabis Movers & Shakers: Acreage, Harborside, Item 9, Halo Collective, TerrAscend, Flora Growth, PathogenDx
BioTech Co. PathogenDx Strengthens Executive Team
Biotechnology company, PathogenDx has bolstered its strategic advisory group and senior leadership team with the appointments of several highly experienced executives who will bring their expertise to the company.
The new leadership appointments include:
Here’s Why Morgan Stanley Downgraded Teradyne
Morgan Stanley analyst Joseph Moore downgraded Teradyne Inc (NASDAQ:TER) to Equal Weight from Overweight with an unchanged price target of $132 (17% upside). …